1.
Jumayev M. The Effects of Glucagon-Like Peptide-1 Agonist Therapy (Semaglutide and Tirzepatide) on Metabolic and Hormonal Parameters in Men with Obesity and Insulin Resistance. GSCMR [Internet]. 2026 Feb. 27 [cited 2026 Mar. 24];1(2):184-8. Available from: https://www.globalconferencehub.org/index.php/mr/article/view/288